NCT00354276View on ClinicalTrials.gov

VNP40101M Followed by Cytarabine in Treating Older Patients With Acute Myeloid Leukemia

PHASE2UnknownINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

December 31, 2008

Conditions
Leukemia
Interventions
DRUG

cytarabine

DRUG

laromustine

Trial Locations (3)

33604

Hopital Haut Leveque, Pessac

90095-1781

Jonsson Comprehensive Cancer Center at UCLA, Los Angeles

CF14 4XW

University Hospital of Wales, Cardiff

Sponsors
All Listed Sponsors
lead

Vion Pharmaceuticals

INDUSTRY

NCT00354276 - VNP40101M Followed by Cytarabine in Treating Older Patients With Acute Myeloid Leukemia | Biotech Hunter | Biotech Hunter